D. Bendixen

1.2k total citations
19 papers, 674 citations indexed

About

D. Bendixen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Bendixen has authored 19 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Bendixen's work include Ion channel regulation and function (14 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Airway Management and Intubation Techniques (3 papers). D. Bendixen is often cited by papers focused on Ion channel regulation and function (14 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Airway Management and Intubation Techniques (3 papers). D. Bendixen collaborates with scholars based in Denmark, Sweden and Norway. D. Bendixen's co-authors include Helle Ørding, T. H. Fagerlund, K. Berg, Tommie V. McCarthy, Bernadette M. Manning, Katherine E. Keating, Kathleen A. Quane, Gunilla Islander, Jasmine Healy and Fergus J. Couch and has published in prestigious journals such as Nature Genetics, Anesthesia & Analgesia and British Journal of Anaesthesia.

In The Last Decade

D. Bendixen

19 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Bendixen Denmark 14 514 399 110 70 67 19 674
Theo M. Hoorntje Netherlands 7 583 1.1× 774 1.9× 90 0.8× 7 0.1× 21 0.3× 10 887
Brechje J. van Beek-Harmsen Netherlands 12 165 0.3× 136 0.3× 28 0.3× 85 1.2× 11 0.2× 14 434
Laura F. Cavallone United States 12 100 0.2× 84 0.2× 81 0.7× 131 1.9× 181 2.7× 20 508
Weijia Du China 12 188 0.4× 68 0.2× 54 0.5× 29 0.4× 59 0.9× 27 495
Gregor W. Nietgen Germany 11 130 0.3× 29 0.1× 77 0.7× 34 0.5× 43 0.6× 20 365
Xia Sheng China 13 124 0.2× 506 1.3× 57 0.5× 37 0.5× 18 0.3× 39 752
Anabelle S. Cornachione Brazil 17 355 0.7× 226 0.6× 31 0.3× 80 1.1× 2 0.0× 28 622
Nobuyuki Ishibashi United States 16 218 0.4× 150 0.4× 25 0.2× 21 0.3× 4 0.1× 54 759
N. N. Zwetnow Sweden 18 104 0.2× 35 0.1× 260 2.4× 27 0.4× 14 0.2× 52 875
Mary A. Knudsen Denmark 12 69 0.1× 209 0.5× 45 0.4× 106 1.5× 4 0.1× 23 529

Countries citing papers authored by D. Bendixen

Since Specialization
Citations

This map shows the geographic impact of D. Bendixen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bendixen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bendixen more than expected).

Fields of papers citing papers by D. Bendixen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bendixen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bendixen. The network helps show where D. Bendixen may publish in the future.

Co-authorship network of co-authors of D. Bendixen

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bendixen. A scholar is included among the top collaborators of D. Bendixen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bendixen. D. Bendixen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Glahn, Klaus P.E., D. Bendixen, Thierry Girard, et al.. (2020). Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. British Journal of Anaesthesia. 125(2). 133–140. 30 indexed citations
2.
Islander, Gunilla, et al.. (2002). Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility. Acta Anaesthesiologica Scandinavica. 46(9). 1144–1149. 10 indexed citations
3.
Ørding, Helle, Gunilla Islander, D. Bendixen, & Eva Ranklev-Twetman. (2000). Between-Center Variability of Results of the In Vitro Contracture Test for Malignant Hyperthermia Susceptibility. Anesthesia & Analgesia. 91(2). 452–457. 15 indexed citations
4.
Ørding, Helle, Gunilla Islander, D. Bendixen, & Eva Ranklev-Twetman. (2000). Between-Center Variability of Results of the In Vitro Contracture Test for Malignant Hyperthermia Susceptibility. Anesthesia & Analgesia. 91(2). 452–457. 13 indexed citations
5.
Bendixen, D., Lene Theil Skovgaard, & Helle Ørding. (1997). Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test. Acta Anaesthesiologica Scandinavica. 41(4). 480–484. 24 indexed citations
6.
Quane, Kathleen A., Helle Ørding, Katherine E. Keating, et al.. (1997). Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. British Journal of Anaesthesia. 79(3). 332–337. 36 indexed citations
7.
Fagerlund, T. H., et al.. (1997). Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation. Clinical Genetics. 52(6). 416–421. 24 indexed citations
8.
Ørding, Helle, et al.. (1997). 4‐chloro‐m‐cresol test ‐ a possible supplementary test for diagnosis of malignant hyperthermia susceptibility. Acta Anaesthesiologica Scandinavica. 41(8). 967–972. 17 indexed citations
9.
Fagerlund, T. H., et al.. (1996). RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clinical Genetics. 49(4). 186–188. 12 indexed citations
10.
Islander, Gunilla, D. Bendixen, Eva Ranklev-Twetman, & Helle Ørding. (1996). Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands. Acta Anaesthesiologica Scandinavica. 40(5). 579–584. 16 indexed citations
11.
Astrup, G., et al.. (1996). Osteogenesis imperfecta and malignant hyperthermia. Anaesthesia. 51(9). 863–865. 37 indexed citations
12.
Ørding, Helle & D. Bendixen. (1996). The Incidence of Malignant Hyperthermia in Denmark. PubMed. 64(7). 21–24. 91 indexed citations
13.
Bendixen, D., et al.. (1994). Lignocaine gel used for lubrication of intranasal and endotracheal tubes in premature neonates. Acta Paediatrica. 83(5). 493–497. 4 indexed citations
14.
Bendixen, D., et al.. (1994). Clinical variability of possible malignant hyperthermia as revealed by two cases.. PubMed. 45(3). 93–8. 1 indexed citations
15.
Fagerlund, T. H., Helle Ørding, D. Bendixen, & K. Berg. (1994). Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia. Clinical Genetics. 46(6). 401–404. 14 indexed citations
16.
Quane, Kathleen A., Jasmine Healy, Katherine E. Keating, et al.. (1993). Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics. 5(1). 51–55. 271 indexed citations
17.
Ørding, Helle & D. Bendixen. (1992). Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.. PubMed. 9(5). 367–76. 15 indexed citations
18.
Bendixen, D. & Helle Ørding. (1990). Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 34(8). 658–661. 1 indexed citations
19.
Bendixen, D., et al.. (1988). INCIDENCE OF SINUSITIS IN PATIENTS WITH NASOTRACHEAL INTUBATION. British Journal of Anaesthesia. 61(2). 231–232. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theo M. Hoorntje Breakdown of academic impact, for papers by Brechje J. van Beek-Harmsen Breakdown of academic impact, for papers by Laura F. Cavallone Breakdown of academic impact, for papers by Weijia Du Breakdown of academic impact, for papers by Gregor W. Nietgen Breakdown of academic impact, for papers by Xia Sheng Breakdown of academic impact, for papers by Anabelle S. Cornachione Breakdown of academic impact, for papers by Nobuyuki Ishibashi Breakdown of academic impact, for papers by N. N. Zwetnow Breakdown of academic impact, for papers by Mary A. Knudsen
Rankless by CCL
2026